Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01

Phase

N/A

Condition

Colorectal Cancer

Colon Cancer

Colon Polyps

Treatment

N/A

Clinical Study ID

NCT04674228

NCI-2020-13238

P30CA015083

NCI-2020-13238

N01CN00042

N01-CN-2012-00042

MAY2016-07-01F

All Genders

Study Summary

This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyposis disease burden after discontinuation of weekly erlotinib.

Eligibility Criteria

Inclusion

Inclusion Criteria:

MAY2016-07-01 study participants for whom medical records are available and accessible

Exclusion

Exclusion Criteria:

MAY2016-07-01 study participants who have opted out of medical records reviews or forwhom consent for medical record review cannot be confirmed/documented

Study Design

May 07, 2021

May 17, 2022

Study Description

PRIMARY OBJECTIVE:

I. To review clinical endoscopy reports, pathology reports, and other medical records related to standard-of-care endoscopic evaluations for all participants in the parent study, MAY2016-07-01, to determine the extent of reports of rapid progression of recurrent polyps after completion intervention and follow up under the parent protocol.

OUTLINE:

Patients who participated in MAY2016-07-01 undergo review of medical records.

Connect with a study center

Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States
Site Not Available
M D Anderson Cancer Center
Houston, Texas 77030
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.